Investigation of the enhanced antitumour potency of STING agonist after conjugation to polymer nanoparticles - Nature Nanotechnology

Investigation of the enhanced antitumour potency of STING agonist after conjugation to polymer nanoparticles – Nature Nanotechnology

Time Stamp: July 12, 2023 10:00 PM
Source Node: 2761397

  • Yum, S., Li, M., Frankel, A. E. & Chen, Z. J. Roles of the cGAS-STING pathway in cancer immunosurveillance and immunotherapy. Annu. Rev. Cancer Biol. 3, 323–344 (2019).

    Article  Google Scholar 

  • Kwon, J. & Bakhoum, S. F. The cytosolic DNA-sensing cGAS–STING pathway in cancer. Cancer Discov. 10, 26 (2020).

    Article  CAS  Google Scholar 

  • Ishikawa, H., Ma, Z. & Barber, G. N. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 461, 788–792 (2009).

    Article  CAS  Google Scholar 

  • Barber, G. N. STING: infection, inflammation and cancer. Nat. Rev. Immunol. 15, 760–770 (2015).

    Article  CAS  Google Scholar 

  • Zitvogel, L., Galluzzi, L., Kepp, O., Smyth, M. J. & Kroemer, G. Type I interferons in anticancer immunity. Nat. Rev. Immunol. 15, 405–414 (2015).

    Article  CAS  Google Scholar 

  • Woo, S.-R. et al. STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors. Immunity 41, 830–842 (2014).

    Article  CAS  Google Scholar 

  • Nicolai, C. J. et al. NK cells mediate clearance of CD8+ T cell–resistant tumors in response to STING agonists. Sci. Immunol. 5, eaaz2738 (2020).

  • Nakamura, T. et al. STING agonist loaded lipid nanoparticles overcome anti-PD-1 resistance in melanoma lung metastasis via NK cell activation. J. Immunother. Cancer 9, e002852 (2021).

  • Fu, J. et al. STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade. Sci. Transl. Med. 7, 283ra252 (2015).

    Article  Google Scholar 

  • Dosta, P. et al. Delivery of stimulator of interferon genes (STING) agonist using polypeptide-modified dendrimer nanoparticles in the treatment of melanoma. Adv. NanoBiomed Res. 1, 2100006 (2021).

    Article  CAS  Google Scholar 

  • Ablasser, A. et al. cGAS produces a 2′-5′-linked cyclic dinucleotide second messenger that activates STING. Nature 498, 380–384 (2013).

    Article  CAS  Google Scholar 

  • Wu, J. et al. Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science 339, 826–830 (2013).

    Article  Google Scholar 

  • Zhang, X. et al. Cyclic GMP-AMP containing mixed phosphodiester linkages is an endogenous high-affinity ligand for STING. Mol. Cell 51, 226–235 (2013).

    Article  CAS  Google Scholar 

  • Lee, S. E. et al. Improvement of STING-mediated cancer immunotherapy using immune checkpoint inhibitors as a game-changer. Cancer Immunol. Immunother. 71, 3029–3042 (2022).

    Article  CAS  Google Scholar 

  • Jneid, B. et al. Selective STING stimulation in dendritic cells primes antitumor T cell responses. Sci. Immunol. 8, eabn6612 (2023).

    Article  CAS  Google Scholar 

  • Wang, H. et al. cGAS is essential for the antitumor effect of immune checkpoint blockade. Proc. Natl Acad. Sci. USA 114, 1637–1642 (2017).

    Article  CAS  Google Scholar 

  • Meric-Bernstam, F. et al. Phase Ib study of MIW815 (ADU-S100) in combination with spartalizumab (PDR001) in patients (pts) with advanced/metastatic solid tumors or lymphomas. J. Clin. Oncol. 37, 2507 (2019).

    Article  Google Scholar 

  • Harrington, K. J. et al. Preliminary results of the first-in-human (FIH) study of MK-1454, an agonist of stimulator of interferon genes (STING), as monotherapy or in combination with pembrolizumab (pembro) in patients with advanced solid tumors or lymphomas. Ann. Oncol. 29, VIII712 (2018).

    Article  Google Scholar 

  • Shae, D. et al. Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy. Nat. Nanotechnol. 14, 269–278 (2019).

    Article  CAS  Google Scholar 

  • Watkins-Schulz, R. et al. A microparticle platform for STING-targeted immunotherapy enhances natural killer cell- and CD8+ T cell-mediated anti-tumor immunity. Biomaterials 205, 94–105 (2019).

    Article  CAS  Google Scholar 

  • Koshy, S. T., Cheung, A. S., Gu, L., Graveline, A. R. & Mooney, D. J. Liposomal delivery enhances immune activation by STING agonists for cancer immunotherapy. Adv. Biosyst. 1, 1600013 (2017).

    Article  Google Scholar 

  • Lin, Z. P. et al. Macrophages actively transport nanoparticles in tumors after extravasation. ACS Nano 16, 6080–6092 (2022).

    Article  CAS  Google Scholar 

  • Miller, M. A. et al. Tumour-associated macrophages act as a slow-release reservoir of nano-therapeutic Pt(IV) pro-drug. Nat. Commun. 6, 8692 (2015).

    Article  CAS  Google Scholar 

  • Korangath, P. et al. Nanoparticle interactions with immune cells dominate tumor retention and induce T cell–mediated tumor suppression in models of breast cancer. Sci. Adv. 6, eaay1601 (2020).

    Article  CAS  Google Scholar 

  • Dane, E. L. et al. STING agonist delivery by tumour-penetrating PEG-lipid nanodiscs primes robust anticancer immunity. Nat. Mater. 21, 710–720 (2022).

    Article  CAS  Google Scholar 

  • Sun, X. et al. Amplifying STING activation by cyclic dinucleotide–manganese particles for local and systemic cancer metalloimmunotherapy. Nat. Nanotechnol. 16, 1260–1270 (2021).

    Article  CAS  Google Scholar 

  • Riley, R. S., June, C. H., Langer, R. & Mitchell, M. J. Delivery technologies for cancer immunotherapy. Nat. Rev. Drug Discov. 18, 175–196 (2019).

    Article  CAS  Google Scholar 

  • Wehbe, M. et al. Nanoparticle delivery improves the pharmacokinetic properties of cyclic dinucleotide STING agonists to open a therapeutic window for intravenous administration. J. Control. Release 330, 1118–1129 (2021).

    Article  CAS  Google Scholar 

  • Lewis, S. M., Williams, A. & Eisenbarth, S. C. Structure and function of the immune system in the spleen. Sci. Immunol. 4, eaau6085 (2019).

  • Bronte, V. & Pittet, MikaelJ. The spleen in local and systemic regulation of immunity. Immunity 39, 806–818 (2013).

    Article  CAS  Google Scholar 

  • Segovia, N., Dosta, P., Cascante, A., Ramos, V. & Borrós, S. Oligopeptide-terminated poly(β-amino ester)s for highly efficient gene delivery and intracellular localization. Acta Biomater. 10, 2147–2158 (2014).

    Article  CAS  Google Scholar 

  • Dosta, P., Ramos, V. & Borrós, S. Stable and efficient generation of poly(β-amino ester)s for RNAi delivery. Mol. Syst. Des. Eng. 3, 677–689 (2018).

    Article  CAS  Google Scholar 

  • Dosta, P. et al. Delivery of anti-microRNA-712 to inflamed endothelial cells using poly(beta-amino ester) nanoparticles conjugated with VCAM-1 targeting peptide. Adv. Healthcare Mater. 10, 2001894 (2021).

  • Nunez-Toldra, R. et al. Improvement of osteogenesis in dental pulp pluripotent-like stem cells by oligopeptide-modified poly(beta-amino ester)s. Acta Biomater. 53, 152–164 (2017).

    Article  CAS  Google Scholar 

  • Dosta, P. et al. Delivery of siRNA to endothelial cells in vivo using lysine/histidine oligopeptide-modified poly(beta-amino ester) nanoparticles. Cardiovasc. Eng. Technol. 12, 114–125 (2021).

    Article  Google Scholar 

  • Dosta, P., Segovia, N., Cascante, A., Ramos, V. & Borrós, S. Surface charge tunability as a powerful strategy to control electrostatic interaction for high efficiency silencing, using tailored oligopeptide-modified poly(beta-amino ester)s (PBAEs). Acta Biomater. 20, 82–93 (2015).

    Article  CAS  Google Scholar 

  • Puigmal, N., Ramos, V., Artzi, N. & Borrós, S. Poly(β-amino ester)s-based delivery systems for targeted transdermal vaccination. Pharmaceutics 15, 1262 (2023).

    Article  CAS  Google Scholar 

  • Vyskocil, S. et al. Identification of novel carbocyclic pyrimidine cyclic dinucleotide STING agonists for antitumor immunotherapy using systemic intravenous route. J. Med. Chem. 64, 6902–6923 (2021).

    Article  CAS  Google Scholar 

  • Alouane, A., Labruère, R., Le Saux, T., Schmidt, F. & Jullien, L. Self-immolative spacers: kinetic aspects, structure–property relationships, and applications. Angew. Chem. Int. Ed. 54, 7492–7509 (2015).

    Article  CAS  Google Scholar 

  • Bargh, J. D., Isidro-Llobet, A., Parker, J. S. & Spring, D. R. Cleavable linkers in antibody–drug conjugates. Chem. Soc. Rev. 48, 4361–4374 (2019).

    Article  CAS  Google Scholar 

  • Gandini, A. The furan/maleimide Diels–Alder reaction: a versatile click–unclick tool in macromolecular synthesis. Prog. Polym. Sci. 38, 1–29 (2013).

    Article  CAS  Google Scholar 

  • Froidevaux, V. et al. Study of the Diels–Alder and retro-Diels–Alder reaction between furan derivatives and maleimide for the creation of new materials. RSC Adv. 5, 37742–37754 (2015).

    Article  CAS  Google Scholar 

  • Harris, J. M. & Chess, R. B. Effect of pegylation on pharmaceuticals. Nat. Rev. Drug Discov. 2, 214–221 (2003).

    Article  CAS  Google Scholar 

  • Fornaguera, C. et al. mRNA delivery system for targeting antigen-presenting cells in vivo. Adv. Healthcare Mater. 7, 1800335 (2018).

    Article  Google Scholar 

  • Blanco, E., Shen, H. & Ferrari, M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat. Biotechnol. 33, 941–951 (2015).

    Article  CAS  Google Scholar 

  • Cheng, Q. et al. Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR–Cas gene editing. Nat. Nanotechnol. 15, 313–320 (2020).

  • Akdis, C. A. & Blaser, K. Mechanisms of interleukin-10-mediated immune suppression. Immunology 103, 131–136 (2001).

    Article  CAS  Google Scholar 

  • Brown, M. A. & Hural, J. Functions of IL-4 and control of its expression. Crit. Rev. Immunol. 17, 1–32 (1997).

    Article  CAS  Google Scholar 

  • Goswami, R. & Kaplan, M. H. A brief history of IL-9. J. Immunol. 186, 3283 (2011).

    Article  CAS  Google Scholar 

  • Harlin, H. et al. Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment. Cancer Res. 69, 3077–3085 (2009).

    Article  Google Scholar 

  • Sivick, K. E. et al. Magnitude of therapeutic STING activation determines CD8+ T cell-mediated anti-tumor immunity. Cell Rep. 25, 3074–3085.e3075 (2018).

    Article  CAS  Google Scholar 

  • Lechner, M. G. et al. Immunogenicity of murine solid tumor models as a defining feature of in vivo behavior and response to immunotherapy. J. Immunother. 36, 477–489 (2013).

    Article  CAS  Google Scholar 

  • Fitzgerald-Bocarsly, P., Dai, J. & Singh, S. Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history. Cytokine Growth Factor Rev. 19, 3–19 (2008).

    Article  CAS  Google Scholar 

  • Liang, H. et al. Host STING-dependent MDSC mobilization drives extrinsic radiation resistance. Nat. Commun. 8, 1736 (2017).

    Article  Google Scholar 

  • Spitzer, M. H. et al. Systemic immunity is required for effective cancer immunotherapy. Cell 168, 487–502.e415 (2017).

    Article  CAS  Google Scholar 

  • Poncette, L., Bluhm, J. & Blankenstein, T. The role of CD4 T cells in rejection of solid tumors. Curr. Opin. Immunol. 74, 18–24 (2022).

    Article  CAS  Google Scholar 

  • Schadt, L. et al. Cancer-cell-intrinsic cGAS expression mediates tumor immunogenicity. Cell Rep. 29, 1236–1248.e1237 (2019).

    Article  CAS  Google Scholar 

  • Carozza, J. A. et al. Extracellular cGAMP is a cancer-cell-produced immunotransmitter involved in radiation-induced anticancer immunity. Nat. Cancer 1, 184–196 (2020).

    Article  CAS  Google Scholar 

  • Madaan, A., Verma, R., Singh, A. T., Jain, S. K. & Jaggi, M. A stepwise procedure for isolation of murine bone marrow and generation of dendritic cells. J. Biol. Methods 1, e1 (2014).

    Article  Google Scholar 

    • Time Stamp:

    More from Nature Nanotechnology